In 2023, the burden of stroke accounted for approximately 157 million disability-adjusted life years (DALYs), ranking second among all non-communicable diseases globally. Although age-standardised ...

Coronavirus disease 2019 (COVID-19), caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was announced as a global pandemic by WHO on 11 March, 2020. Although ...

National Health Plan (NHP) 2021–2030 articulates a vision of “a healthy and prosperous nation where health and wellbeing are enjoyed by all,” anchored in evidence-based innovation as a fundamental ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...

Each year, millions of individuals are admitted to intensive care units (ICUs) worldwide; for every patient treated in the ICU, there is often at least one other unseen vulnerable individual—the ...

As the global population ages, older adults with atherosclerotic cardiovascular disease (ASCVD) are projected to drive a ...

Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...

Men and partners are important contributors to the health of future generations, yet their own preconception health and wellbeing remain secondary considerations in research, practice, and policy.

There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...

In this large international cohort of immunocompromised patients with ARF, we identified key risk and protective factors for mortality and intubation. These findings could improve outcomes by ...

The care of immunocompromised adults with acute respiratory failure (ARF) remains one of the greatest challenges of intensive care medicine.1 Management of these patients is challenging because ...